Julio C. Chavez, MD¹, Caron A. Jacobson, MD^2*, Alison R. Sehgal, MD³, Sattva S. Neelapu, MD⁴, David G. Maloney, MD, PhD⁵, Gilles Salles, MD, PhD⁶, Basem M. William, MD, MRCP⁷, Yin Yang, MS^8*, Lovely Goyal, PhD^8*, Justin Chou, PhD^8*, Vicki Plaks, LLB, PhD^8* and Mauro P. Avanzi, MD, PhD^8*

¹University of South Florida H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
²Dana-Farber Cancer Institute, Boston, MA
³UPMC Hillman Cancer Center, Pittsburgh, PA
⁴The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Fred Hutchinson Cancer Research Center, Seattle, WA
⁶Centre Hospitalier Lyon Sud, Pierre-Bénite, France
⁷The Ohio State University Comprehensive Cancer Center, Columbus, OH
⁸Kite, a Gilead Company, Santa Monica, CA

Michael Wang, MD¹, Preetesh Jain, MBBS, MD, DM, PhD², Yixin Yao, PhD³, Yang Liu, PhD^2*, Shuangtao Zhao, PhD^4*, Holly Hill^2*, Omar Moghrabi^2*, Hun Ju Lee, MD², Felipe Samaniego, MD², Jason Westin, MD², Loretta J. Nastoupil, MD⁵, Rashmi Kanagal-Shamanna, MD⁶, Chi Young Ok, MD⁷, Wendy Chen^2*, Onyeka Oriabure^2*, Yuxuan Che^2*, Yijing Li, MS^2*, Lei Feng, MS^8*, Graciela M. Nogueras González, MPH^5*, Guofang Xu, MD^9*, Nicolaus Wagner-Bartak, MD^9*, Selvi Thirumurthi^10*, David Santos^11*, Guilin Tang, MD^7*, Francisco Vega, MD, PhD¹², C. Cameron Yin, MD, PhD⁷, Michelle Avellaneda^2*, Maria Badillo, MSN, RN, OCN, CCRP^2*, Christopher Flowers, MD, MS² and Linghua Wang, PhD^4*

¹Department of Lymphoma and Myeloma, U.T. M.D. Anderson Cancer Center, Houston, TX
²Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX
⁴Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Department of Hematopathology, Division of Pathology/Lab Medicine, University of Texas MD Anderson Cancer Center, Houston, TX
⁷Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁸Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
⁹Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁰Department of Gastroenterology, The University of Texas MD Anderson Cancer Center, Houston
¹¹Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston
¹²Division of Hematopathology, Department of Pathology and Laboratory Medicine, MD Anderson Cancer Center, Houston, TX

Mats Jerkeman, MD, PhD^1,2, Martin Hutchings, MD, PhD^3*, Riikka Räty, MD, PhD^4*, Karin Fahl Wader, MD, PhD^5*, Anna Laurell, MD, PhD^6*, Jacob H. Christensen, MD^7*, Hanne Kuitunen, MD^8*, Christian Winther Eskelund, MD, PhD^9*, Kirsten Groenbaek, MD, DMSc^10*, Carsten Utoft Niemann, MD, PhD¹¹, Christian H. Geisler, MD, PhD¹² and Arne Kolstad, MD, PhD^13*

¹Department of Oncology, Skane University Hospital, Lund, Skaane Laen, Sweden
²Department of Oncology, Lund University and Skane University Hospital, Lund, Sweden
³Department of Hematology; Finsen Centre, National Hospital, Copenhagen University Hospital, Copenhagen, Denmark
⁴Department of Hematology, Helsinki University Hospital, HUS, FIN
⁵Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway
⁶University Hospital Uppsala, Uppsala, SWE
⁷Odense University Hospital, Odense, Denmark
⁸Department of Oncology and Radiotherapy, Oulu University Hospital, Oulu, Finland
⁹Department of Hematology, Rigshospitalet, Copenhagen University Hospital, CPH N, Denmark
¹⁰The Epi-/Genome Laboratory, Department of Hematology/Rigshospitalet, Copenhagen, DNK
¹¹Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen O, Denmark
¹²Clinic 4042, Rigshospitalet Hematology, Copenhagen, DNK
¹³Department of Oncology, Oslo University Hospital, Radiumhospitalet, Oslo, Norway

Aung M Tun, MD¹, Raphael Mwangi^2*, Brian K. Link, MD³, Andrew L. Feldman, MD⁴, Matthew J. Maurer, MS⁵, Thomas E. Witzig, MD⁶, Carrie A. Thompson, MD⁶, Anne J. Novak, PhD⁶, Jose C Villasboas, MD⁶, Umar Farooq, MD⁷, Sergei Syrbu, MD, PhD^8*, James R. Cerhan, MD, PhD⁵ and Thomas M. Habermann, MD⁶

¹University of Kansas Cancer Center, University of Kansas, Kansas City, KS
²Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN
³Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA
⁴Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
⁵Department of Health Sciences Research, Mayo Clinic, Rochester, MN
⁶Division of Hematology, Mayo Clinic, Rochester, MN
⁷Division of Hematology, Oncology, Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA
⁸Division of Hematology, Oncology and Bone Marrow Transplantation, University of Iowa, Iowa City, IA

Michael Wang, MD¹, Simon Rule, MD, PhD^2*, Pier Luigi Zinzani, MD³, Andre H. Goy, MD⁴, Rene-Olivier Casasnovas, MD^5*, Stephen D. Smith, MD⁶, Gandhi Laurent Damaj, MD, PhD⁷, Jeanette K. Doorduijn, MD, PhD⁸, Thierry Lamy^9*, Franck Morschhauser, MD, PhD^10*, Carlos Panizo, MD, PhD^11*, Bijal Shah, MD¹², Andrew Davies, MD, PhD^13*, Richard Eek, FRACP.^14*, Jehan Dupuis, MD^15*, Eric Jacobsen, MD^16*, Arnon P. Kater, MD, PhD¹⁷, Steven Le Gouill, MD, PhD¹⁸, Lucie Oberic, MD^19*, Tadeusz Robak, MD PhD²⁰, Preetesh Jain, MBBS, MD, DM, PhD¹, Graham Brock, PhD^21*, Priti Patel, MD²¹, Lin Tao^21* and Monika Dlugosz-Danecka, MD, PhD^22*

¹MD Anderson Cancer Center, University of Texas, Houston, TX
²Plymouth University Medical School, Plymouth, United Kingdom
³Institute of Hematology "Seràgnoli" University of Bologna, Bologna, Italy
⁴John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
⁵CHU Dijon - Hôpital d’Enfants, Dijon, France
⁶Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA
⁷Institut d’Hématologie de Basse-Normandie, Caen, France
⁸Erasmus MC, HOVON Lunenburg Lymphoma Phase I/II Consortium, Rotterdam, Netherlands
⁹CHU de Rennes, Rennes, France
¹⁰Univ. Lille, CHU Lille, EA 7365—GRITA—Groupe de Recherche sur les Formes Injectables et les Technologies Associées, F-59000, Lille, France
¹¹Clínica Universidad de Navarra, Pamplona, Spain
¹²Moffitt Cancer Center, Tampa, FL
¹³Cancer Research UK Experimental Cancer Medicines Centre, University of Southampton Faculty of Medicine, Southampton, United Kingdom
¹⁴Border Medical Oncology, Albury, VIC, Australia
¹⁵Unité Hémopathies Lymphoïdes, AP-HP Hôpital Henri Mondor, Créteil, France
¹⁶Dana Farber Cancer Institute, Harvard Medical School, Boston, MA
¹⁷Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, HOVON Lunenburg Lymphoma Phase I/II Consortium, Amsterdam, Netherlands
¹⁸CHU de Nantes—Hotel Dieu, Nantes, France
¹⁹Institut Universitaire du Cancer—Oncopole Toulouse (IUCT-O), Toulouse, France
²⁰Copernicus Memorial Hospital, Medical University of Lodz, Lodz, Poland
²¹Acerta Pharma, South San Francisco, CA
²²Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland

Patrizia Mondello, MD, PhD, MSc¹, Paolo Strati, MD², Reid W Merryman, MD³, Erel Joffe, MD, MSc¹, Marco Ruella, MD⁴, Venkatraman Seshan, PhD^5*, Frederique St Pierre^6*, Ajay Major, MD, MBA⁷, Priyanka Pophali, MD⁸, Megan Fiasconaro^5*, Carrie I Ho, MD⁹, Eleanor Neal^10*, Chao-Ming Lai^10*, Gabriela Spilberg, MD^11*, Saurabh Rajguru, MD^8*, Jakub Svoboda, MD⁹, Thomas E. Witzig, MD⁶, Sonali M. Smith, MD⁷, Philippe Armand, MD, PhD³, Loretta J. Nastoupil, MD¹⁰, Stephen M. Ansell, MD, PhD⁶, Andrew D Zelenetz, MD, PhD¹, Anas Younes¹ and Gilles Salles¹

¹Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
²Department of Lymphoma and Myeloma; Department of Translational Molecular Pathology, MD Anderson Cancer Center:, Houston, TX
³Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁴Division of Hematology-Oncology, University of Pennsylvania, Philadelphia, PA
⁵Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
⁶Division of Hematology, Mayo Clinic, Rochester, MN
⁷Department of Oncology, University of Chicago, Chicago, IL
⁸Division of Hematology, University of Wisconsin-Madison, Madison, WI
⁹Division of Hematology-Oncology, University of Pennsylvania School of Medicine, Philadelphia, PA
¹⁰Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
¹¹Jefferson Radiology, Hartford, CT

Preetesh Jain, MBBS, MD, DM, PhD¹, Yixin Yao, PhD², Shuangtao Zhao, PhD^3*, Yang Liu, PhD^1*, Holly Hill^1*, Yuxuan Che^1*, Yijing Li, MS^1*, Alexa A Jordan, BS^1*, Joseph McIntosh, BS^1*, Hun Ju Lee, MD¹, Raphael Eric Steiner, MD¹, Felipe Samaniego, MD¹, Jason Westin, MD¹, Loretta J. Nastoupil, MD⁴, Ranjit Nair^1*, Sairah Ahmed, MD⁵, Chi Young Ok, MD⁶, Rashmi Kanagal-Shamanna, MD⁷, Onyeka Oriabure^1*, Guofang Xu, MD^8*, Wendy Chen^1*, Omar Moghrabi^1*, Chloe Marie McClain^1*, Maria Badillo, MSN, RN, OCN, CCRP^1*, Selvi Thirumurthi^9*, David Santos^10*, Cezar Iliescu, MD^11*, C. Cameron Yin, MD, PhD⁶, Shaoying Li, MD^12*, Guilin Tang, MD^6*, Francisco Vega, MD, PhD¹³, Sattva S. Neelapu, MD¹, Christopher Flowers, MD, MS¹, Linghua Wang, PhD^3* and Michael Wang, MD¹⁴

¹Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX
³Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Lymphoma/Myeloma, MD Anderson Cancer Center, Houston, TX
⁶Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁷Department of Hematopathology, Division of Pathology/Lab Medicine, University of Texas MD Anderson Cancer Center, Houston, TX
⁸Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
⁹Department of Gastroenterology, The University of Texas MD Anderson Cancer Center, Houston
¹⁰Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston
¹¹Department of Cardiology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
¹²Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX
¹³Division of Hematopathology, Department of Pathology and Laboratory Medicine, MD Anderson Cancer Center, Houston, TX
¹⁴Department of Lymphoma and Myeloma, U.T. M.D. Anderson Cancer Center, Houston, TX

Lu Zhang, MD^1*, Ming-nan Jia, M.D.^1*, Ai-lin Zhao, MD^1*, Jun Feng, MD^1*, Xin-xin Cao, MD^1*, Yan Zhang, MD^1*, Ming-hui Duan, MD^1*, Dao-Bin Zhou^1*, Yujun Dong, MD^2* and Jian Li, MD¹

¹Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, Beijing, China
²Department of Hematology, Peking University First Hospital, Beijing, China

Pier Luigi Zinzani, MD¹, Vincent Delwail^2*, Shankara Paneesha, MD³, Simon Rule, MD, PhD^4*, Alejandro Martin Garcia-Sancho, MD, PhD^5*, Ana Marin-Niebla, MD, PhD^6*, Gilles Salles, MD, PhD⁷, Juan-Manuel Sancho, MD, PhD^8*, Vibeke Vergote, MD^9*, Vittorio Ruggero Zilioli, MD^10*, Fred Zheng, MD^11*, Douglas J DeMarini, PhD^11*, Wei Jiang, PhD^11* and Amitkumar Mehta, MD¹²

¹Institute of Hematology "Seràgnoli" University of Bologna, Bologna, Italy
²CHU Poitiers, Poitiers, France
³Department of Haematology & Stem Cell Transplantation, Birmingham Heartlands Hospital, Birmingham, United Kingdom
⁴Plymouth University Hospitals NHS Trust, Plymouth, United Kingdom
⁵Hospital Universitario de Salamanca, IBSAL, Salamanca, Spain
⁶Hospital Universitari Vall d’Hebron, Barcelona, Spain
⁷University Hospital of Lyon, Lyon, France
⁸ICO-Hospital Germans Trias i Pujol, Badalona, Spain
⁹University Hospitals Leuven, Leuven, Belgium
¹⁰ASST Grande, Ospedale Metropolitano Niguarda, Milan, Italy
¹¹Incyte Corporation, Wilmington, DE
¹²UAB School of Medicine, Birmingham, AL

Armando Santoro^1*, Alison J. Moskowitz, MD², Silvia Ferrari, MD^3*, Carmelo Carlo-Stella, MD⁴, Michelle A. Fanale, MD⁵, Stephen Francis^6*, Mariana Sacchi, MD^6* and Kerry J. Savage, MD MSc⁷

¹Humanitas Clinical and Research Center IRCCS, Humanitas University, Milano, Italy
²Memorial Sloan Kettering Cancer Center, New York, NY
³Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy
⁴Humanitas Clinical and Research Center, and Humanitas University, Milan, Italy
⁵Seattle Genetics, Bothell, WA
⁶Bristol-Myers Squibb Company, Princeton, NJ
⁷Department of Medical Oncology, BC Cancer, Vancouver, BC, Canada

Giselle K. Perez, PhD^1*, Fangxin Hong, PhD², Andrew M. Evens, DO, MMSc³, Thomas M. Habermann, MD⁴, Ranjana Advani, MD⁵, Stephen M. Ansell, MD, PhD⁶, Puneet S. Cheema, MD^7*, Philip A. Dy, MD^8*, Timothy E. O'Brien, MD⁹, Jane N. Winter, MD¹⁰, Julie E. Chang, MD¹¹, David Cella, PhD^12*, Brad S. Kahl, MD¹³ and Lynne I. Wagner, PhD^14*

¹Massachusetts General Hospital/Harvard Medical School, Boston, MA
²Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA
³Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
⁴Division of Hematology, Mayo Clinic, Rochester, MN
⁵Division of Oncology, Department of Medicine, Saul A. Rosenberg Professor of Lymphoma, Stanford Cancer Institute, Stanford, CA
⁶Mayo Clinic, Rochester, MN
⁷Saint John's Hospital, Maplewood, MN
⁸Cancer Care Specialists, Effingham, IL
⁹MetroHealth Medical Center, Cleveland, OH
¹⁰Division of Hematology and Oncology, Northwestern University, Chicago, IL
¹¹University of Wisconsin School of Medicine and Public Health, Madison, WI
¹²Northwestern University, Feinberg School of Medicine, Chicago, IL
¹³Washington University School of Medicine in St. Louis, Saint Louis, MO
¹⁴Social Sciences and Health Policy, Wake Forest School of Medicine, Winston-Salem, NC

Gilles Salles, MD, PhD¹, Hervé Tilly, MD², Aristeidis Chaidos, MD, PhD^3*, Pam McKay, MD^4*, Tycel J. Phillips, MD⁵, Sarit E Assouline, MD, MSc⁶, Connie Lee Batlevi, MD, PhD⁷, Philip Campbell, MBBS⁸, Vincent Ribrag, MD⁹, Gandhi Laurent Damaj, MD, PhD^10*, Michael Dickinson, MBBS, FRACP, FRCPA¹¹, Wojciech Jurczak, MD, PhD¹², Maciej Kaźmierczak, MD, PhD^13*, Stephen Opat, FRACP, FRCPA, MBBS^14*, John A. Radford, MD, FMedSci^15*, Anna Schmitt, MD^16*, Jennifer Whalen, DHS^17*, Anthony Hamlett, PhD^18*, Beth Kamp, PharmD^18*, Deyaa Adib, MD^18* and Franck Morschhauser, MD, PhD^19*

¹Lyon-Sud Hospital Center, Pierre-Benite, France
²Service d'hématologie, Centre de Lutte Contre le Cancer Henri Becquerel, Rouen, France
³Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Foundation Trust, London, United Kingdom
⁴Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom
⁵Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI
⁶Division of Hematology, Sir Mortimer B. Davis-Jewish General Hospital, Department of Oncology, McGill University, Montreal, QC, Canada
⁷Memorial Sloan Kettering Cancer Center, New York, NY
⁸Barwon Health, University Hospital Geelong, Geelong, VIC, Australia
⁹Gustave Roussy, Villejuif, France
¹⁰Department of Hematology, Hematology Institute University Hospital School of Medicine, Caen, France
¹¹Clinical Haematology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
¹²UJCM, Krakow, Poland
¹³Examen sp. z o.o,, Poznan, Poland
¹⁴Clinical Haematology, Monash Health and Monash University, Clayton, VIC, Australia
¹⁵The University of Manchester and The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom
¹⁶Institut Bergonié, Bordeaux, France
¹⁷Data Management Department, Epizyme, Cambridge, MA
¹⁸Epizyme, Inc., Cambridge, MA
¹⁹Department of Hematology, Centre Hospitalier Régional Universitaire De Lille, Lille, France

Yuqin Song, MD, PhD^1*, Yongping Song, MD^2*, Lihong Liu, MD^3*, Mingzhi Zhang, MD^4*, Zhiming Li, MD, PhD^5*, Chunyan Ji, MD^6*, Wei Xu, MD, PhD⁷, Ting Liu, MD, PhD⁸, Bing Xu, MD, PhD^9*, Xin Wang, MD, PhD¹⁰, Sujun Gao^11*, Huilai Zhang, MD, PhD^12,13*, Yu Hu, MD^14*, Yan Li^15*, Ying Cheng^16*, Haiyan Yang, MD, PhD^17*, Junning Cao, MD^18*, Zunmin Zhu, MD^19*, Jianda Hu, MD, PhD²⁰, Wei Zhang^21*, Hongmei Jing, MD, PhD²², Kaiyang Ding^23*, Zhengguang Lu^24*, Bin Zhang, PhD^24*, Renbin Zhao, PhD^25*, Zhixin Xu, MD, PhD^25* and Jun Zhu, BS^26,27

¹Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China
²Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan Province, China
³The Fourth Hospital of Hebei Medical University, Shijiazhuang, China
⁴Department of Oncology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
⁵Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China
⁶Department of Hematology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China
⁷Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
⁸Department of Hematology, West China Hospital of Sichuan University, Chengdu, China
⁹Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen, China
¹⁰Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China
¹¹Jilin University First Hospital, Changchun, China
¹²Department of Lymphoma, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
¹³Department of Lymphoma, Sino-US Center for Lymphoma and Leukemia Research, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China
¹⁴Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
¹⁵The First Hospital of China Medical University, Shenyang, China
¹⁶Jilin Cancer Hospital, Changchun, CHN
¹⁷Department of Lymphoma, Zhejiang Cancer Hospital, Hangzhou, China
¹⁸Fudan University Shanghai Cancer Center, Shanghai, China
¹⁹Hematology, Henan Provincial People's Hospital, Zhengzhou, CHN
²⁰Department of Hematology, Fujian Institute of Hematology, Fujian Provincial Key Laboratory of Hematology, Fujian Medical University Union Hospital, Fuzhou, China
²¹Peking Union Medical College Hospital, Beijing, Beijing, CHN
²²Department of Hematology, Peking University Third Hospital, Beijing, China
²³The First Affiliated Hospital of University of Science and Technology of China, Hefei, China
²⁴Beijing InnoCare Pharma Tech Co., Ltd, Beijing, China
²⁵Beijing InnoCare Pharma Tech Co., Ltd., Beijing, China
²⁶Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute, Beijing, Beijing, China
²⁷Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute, Beijing, China

Brian T. Hill, MD¹, Deepa Jagadeesh, MD, MPH², Alex V. Mejia Garcia, MD³, Robert M. Dean, MD³, Omer N. Koc, MD⁴, Matt Kalaycio, MD³, Kirsten M Boughan, DO^5,6, Brenda W. Cooper, MD⁵, Allison M. Winter, MD⁴, Wesam B. Ahmed, MD^7*, Brad Pohlman, MD⁴, Christopher D'Andrea, PA-C^4*, Kelsey Holkovic, RN^4*, Ashley Morrison, RN^4*, Paolo Caimi, MD⁵ and Mitchell R Smith, MD, PhD⁸

¹Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic Foundation, Cleveland, OH
²Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic, Solon, OH
³Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH
⁴Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
⁵University Hospitals Seidman Cancer Center, Cleveland, OH
⁶Adult Hematologic Malignancies & Stem Cell Transplant Section, University Hospitals Seidman Cancer Center, Cleveland, OH
⁷Florida, Cleveland Clinic, Weston, FL
⁸George Washington University Cancer Center, Washington, DC

Juan Pablo Alderuccio, MD¹, Anne W. Beaven, MD², Geoffrey Shouse, DO, PhD³, Narendranath Epperla, MD, MS⁴, Alexandra Stefanovic, MD⁵, Pallawi Torka, MD⁶, Jorge J. Castillo, MD⁷, Lisa Argnani^8*, Timothy J Voorhees, MD², Ash B Alpert, MD, MFA⁹, Sayan Chowdhury, PhD^10*, Isildinha M. Reis, PhD^11*, Wei Zhao, MD, MS^12*, Dali Edwards^13*, Peter Martin, FRCPC, MD, MS¹⁴, Manali Kamdar, MD¹⁵, Alex F. Herrera, MD¹⁶, Jonathan W. Friedberg, MD, MSSc¹⁷, Pier Luigi Zinzani, MD¹⁸ and Izidore S. Lossos, MD¹

¹Sylvester Comprehensive Cancer Center, University of Miami School of Medicine, Miami, FL
²Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
³Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA
⁴The Ohio State University James Comprehensive Cancer Center, Columbus, OH
⁵Duke University, Durham
⁶Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY
⁷Bing Center for Waldenström Macroglobulinemia, Dana Farber Cancer Institute, Boston, MA
⁸Institute of Hematology “L.e A. Seràgnoli”, University of Bologna, Bologna, Italy
⁹Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY
¹⁰Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
¹¹Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, FL
¹²University of Miami, Miller School of Medicine, Miami, FL
¹³Roswell Park Comprehensive Cancer Center, Buffalo
¹⁴Weill Cornell Medicine-New York Presbyterian Hospital, New York, NY
¹⁵Division of Hematology, Hematologic Malignancies and Stem Cell Transplantation, University of Colorado Cancer Center, Denver, CO
¹⁶City of Hope, Duarte, CA
¹⁷Division of Hematology/Oncology, University of Rochester, Rochester, NY
¹⁸Istituto di Ematologia "Seràgnoli", Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università degli Studi, Bologna, Italy

Solomon A. Graf, MD¹, Ryan C. Lynch, MD¹, Ted A Gooley, PhD^2*, Chaitra S. Ujjani, MD¹, Peter Wilcox^3*, Sabrina Wilcox^3*, David G. Coffey, MD¹, Andrew J. Cowan, M.D.¹, Stephen D. Smith, MD¹, Mazyar Shadman, MD⁴, Edus H. Warren, MD, PhD⁵, Edward Libby, MD¹, Colin D. Godwin, MD, MPhil¹, Ryan D. Cassaday, MD¹, Jonathan R. Fromm, MD, PhD⁶ and Ajay K. Gopal, MD⁵

¹University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA
²Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
³University of Washington/Seattle Cancer Care Alliance, Seattle
⁴Uw/Fred Hutchinson Cancer Research Center, Seattle, WA
⁵University of Washington/Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA
⁶Department of Laboratory Medicine, University of Washington, Seattle, WA

John P. Leonard, MD¹, Connie Lee Batlevi, MD, PhD², Nashat Gabrail, MD^3*, John M. Pagel, MD, PhD⁴, Jay Yang, PhD^5*, Jennifer Whalen, DHS^6*, Deyaa Adib, MD^5* and Franck Morschhauser, MD, PhD^7*

¹Weill Cornell Medical College, Pelham Manor, NY
²Memorial Sloan Kettering Cancer Center, New York, NY
³Gabrail Cancer Center, Canton, OH
⁴Swedish Cancer Institute, Seattle, WA
⁵Epizyme, Inc., Cambridge, MA
⁶Data Management Department, Epizyme, Cambridge, MA
⁷Department of Hematology, Centre Hospitalier Régional Universitaire De Lille, Lille, France

Xin-xin Cao, MD^1*, Shuhua Yi, MD^2*, Zhongxing Jiang, MD^3*, Jingsong He, MD^4*, Wei Yang^5*, Juan Du Jr., MD^6*, Chunyan Sun, MD, PhD^7*, Yu Wu, MD⁸, Chen Wenming, MD^9*, Xiao-jun Liu^10*, Bingzong Li, MD, PhD¹¹, Chunrui Li, MD, PhD¹², Wei Sang^13*, Qin-hua Liu^14*, Xiaoxia Chu^15*, Li Fei¹⁶, Ou Bai^17*, Min Mao^18*, Rong Fu, PhD^19*, Wei WANG, MD^20*, Lihong Liu, MD^21*, Luqun Wang, MD, PhD^22*, Yujun Dong, MD^23*, Jun Luo, DO^24*, Zhenling Li^25*, Yongqiang Wei^26*, Qi-ke Zhang^27*, Jing Liu^28*, Kaiyang Ding^29*, Liang Zou^30*, Bi-yun Chen^31*, Luoming Hua, PhD^32*, Hongmei Jing^33*, Juan He, PhD^34*, Liang Wang^35*, Lugui Qiu, MD³⁶ and Jian Li, MD¹

¹Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
²lymphoma and myeloma center, National Clinical Research Center for Blood Diseases, State Key Laboratory of Experimental Hematology, Blood Diseases Hospital & Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
³Department of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
⁴Department of Hematology, Bone Marrow Transplantation Center, The First Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang, China
⁵Shengjing Hospital of China Medical University, Shengjing, China
⁶Department of Hematology, Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, The Second Military Medical University, Shanghai, China
⁷Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Institute of Hematology, Wuhan, China
⁸Department of Hematology and Hematology Research Laboratory, West China Hospital, Sichuan University, Chengdu, China
⁹Department of Hematology, Beijing Chao-Yang Hospital of Capital Medical University, Beijing, China
¹⁰Department of Hematology, The Second Hospital of Hebei Medical University, Hebei, China
¹¹Department of Hematology, the Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
¹²Department of Hematology, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China
¹³Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China
¹⁴Department of Hematology, The First Affiliated Hospital of Anhui Medical University, Anhui, China
¹⁵Department of Hematology, Yantai Yuhuangding Hospital, Yantai, China
¹⁶the First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, China
¹⁷Department of Hematology, The First Affiliated Hopital of Jilin University, Jilin, China
¹⁸Department of Hematology, Xinjiang Uiger Municipal People’s Hospital, Xinjiang, China
¹⁹Tianjin Medical University General Hospital, Tianjin, China
²⁰Department of Hematology, The Affiliated Hospital of Qingdao University, QING DAO, CHN
²¹The Fourth Hospital of Hebei Medical University, Shijiazhuang, China
²²Department of Hematology, Qilu Hospital of Shandong University, Jinan, Shandong, China
²³Department of Hematology, Peking University First Hospital, Beijing, China
²⁴Department of Hematology, The First Affiliated Hospital of Guangxi Medical University, Guangxi, China
²⁵Department of Hematology, China-Japan Friendship Hospital, Beijing, CHN
²⁶Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
²⁷Department of Hematology, Gansu Provincial Hospital, Gansu, China
²⁸Department of Hematology, The Third Xiangya Hospital of Central South University, Hunan, China
²⁹The First Affiliated Hospital of University of Science and Technology of China, Hefei, China
³⁰Department of Hematology, Wuhan No.1 Hospital, Wuhan, China
³¹Department of Hematology, Fujian Provincial Hospital, Fujian, China
³²The Affiliated Hospital of Hebei University, Baoding, China
³³Peking University Third Hospital, Beijing, China
³⁴Department of Hematology, The First Hospital of China Medical University, Shenyang, CHN
³⁵Department of Hematology, Zhujiang Hospital of Southern Medical University, Guangdong, China
³⁶State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

Leslie L. Popplewell, MD, FACP¹, Agnes Rethy, MD^2*, Kristina Dabovic, PharmD^2* and Christine Burnett, PhD^2*

¹City of Hope, Duarte, CA
²Molecular Templates, Inc., Jersey City, NJ

Sheeba K. Thomas, MD¹, Soung-chul Cha, PhD^2*, Sapna R Parshottam, MSc^3*, Sheetal S. Rao, PhD^3*, Jasper B. Olsem, B.S.N.^4*, Brandon N. Crumpton^4*, Szymon Szymura, Ph.D.^2*, Zhe Wang, Ph.D.^2*, Aaron Anderson^2*, Lei Feng, MS^5*, Hans C. Lee, MD¹, Elisabet E. Manasanch, M.D.¹, Krina K. Patel, M.D.⁶, Donna M. Weber, MD¹, Robert Z. Orlowski, MD, PhD⁷, Sattva S. Neelapu, MD¹ and Larry W. Kwak, MD, PhD⁸

¹Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
²Toni Stephenson Lymphoma Center and Department of Hematology and Hematopoietic Stem Cell Transplantation, City of Hope National Medical Center, Duarte, CA
³Department of Stem Cell Transplantation Research, University of Texas M.D. Anderson Cancer Center, Houston, TX
⁴Department of Lymphoma and Myeloma, University of Texas M.D. Anderson Cancer Center, Houston, TX
⁵University of Texas MD Anderson Cancer Center, Houston, TX
⁶Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁷Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX
⁸Deputy Director, City of Hope Comprehensive Cancer Center, Duarte, CA

Arushi Khurana, MBBS¹, Raphael Mwangi^2*, Stephen M. Ansell, MD, PhD³, Thomas M. Habermann, MD¹, James R. Cerhan, MD, PhD¹, Christopher Strouse, MD⁴, Brian K. Link, MD⁴, Yucai Wang, MD, PhD¹, Rebecca L. King, MD⁵, William R. Macon, MD^5*, Jose C Villasboas, MD⁶, Thomas E. Witzig, MD¹, Matthew J. Maurer, MS⁷ and Grzegorz S. Nowakowski, MD¹

¹Division of Hematology, Mayo Clinic, Rochester, MN
²Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN
³Mayo Clinic, Rochester, MN
⁴Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA
⁵Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
⁶Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
⁷Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN

Daniel Guy, MD¹, Marcus Watkins, PhD^2*, Fei Wan^3*, Nancy L. Bartlett, MD^4*, Amanda F Cashen, MD⁵, Todd A Fehniger, MD, PhD⁶, Armin Ghobadi, MD^7*, Neha Mehta-Shah, MD⁸ and Brad S. Kahl, MD⁹

¹Providence Cancer Institute, Portland, OR
²Barnes-Jewish Hospital, Washington University in St. Louis, St. Louis, MO
³Washington University in St. Louis, St. Louis, MO
⁴Washington University School of Medicine Siteman Cancer Center, St. Louis, MO
⁵Department of Medicine, Washington Univ. School of Med., Saint Louis, MO
⁶Department of Medicine, Washington University School of Medicine, Saint Louis, MO
⁷Washington University School of Medicine, Saint Louis, MO
⁸Department of Medicine, Division of Oncology, Washington University, Olivette, MO
⁹Washington University School of Medicine in St. Louis, Saint Louis, MO

Preetesh Jain, MBBS, MD, DM, PhD¹, Shaojun Zhang, PhD^2*, Rashmi Kanagal-Shamanna, MD³, Lucy Navsaria, MB BCh BAO^1*, Chi Young Ok, MD⁴, Guilin Tang, MD^4*, C. Cameron Yin, MD, PhD⁴, Maria Badillo, MSN, RN, OCN, CCRP^1*, Wendy Chen^1*, Onyeka Oriabure^1*, Hun Ju Lee, MD¹, Jason Westin, MD¹, Loretta J. Nastoupil, MD⁵, Omar Moghrabi^1*, Yuxuan Che^1*, Felipe Samaniego, MD¹, Sairah Ahmed, MD⁶, Ranjit Nair^1*, Shaoying Li, MD^7*, Francisco Vega, MD, PhD⁸, Christopher Flowers, MD, MS¹, Linghua Wang, PhD^2* and Michael Wang, MD⁹

¹Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Hematopathology, Division of Pathology/Lab Medicine, University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Department of Lymphoma/Myeloma, MD Anderson Cancer Center, Houston, TX
⁷Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX
⁸Division of Hematopathology, Department of Pathology and Laboratory Medicine, MD Anderson Cancer Center, Houston, TX
⁹Department of Lymphoma and Myeloma, U.T. M.D. Anderson Cancer Center, Houston, TX

Sudipto Mukherjee, MD, PhD, MPH¹, Rabecka Martin, PhD^2*, Brenda Sande^2*, Chad Glen, PhD^3*, Jeremy Paige, MD, PhD^3*, Suresh Yarlagadda, MD, MPH^3* and David C Fajgenbaum, MD, MBA, MSc^4,5

¹Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
²EUSA Pharma, Boston, MA
³HVH Precision Analytics, Wayne, PA
⁴University of Pennsylvania, Philadelphia, PA
⁵Castleman Disease Collaborative Network, Philadelphia, PA

Hsu-Chih Chien, PhD, MSc^1,2*, Deborah Kay Morreall, BS^1,2*, Vikas Patil, MS^1,2*, Kelli M Rasmussen, BSc, MS^1,2*, Christina Yong, MA^1,2*, Catherine Li, PhD^2,3*, Zachary R Burningham, PhD^1,2*, Brian C Sauer, PhD^1,2* and Ahmad S Halwani, MD, PhD^1,2,4

¹George E. Wahlen Veterans Health Administration, Salt Lake City, UT
²Division of Epidemiology, VERITAS, University of Utah, Salt Lake City, UT
³George E. Whalen Veterans Health Administration, Salt Lake City, UT
⁴Huntsman Cancer Institute, Salt Lake City, UT

Suzanne O Arulogun, MBBS¹, Michael P Lunn^2*, Chandrashekar Hoskote^2*, Aisling Carr, PhD FRCP^2*, Oliver Tomkins, BMBS, MRCP^1*, Ali Rismani, FRCPath^1*, Ashutosh D. Wechalekar^3* and Shirley D'Sa, MD, FRCPath^1*

¹University College London Hospitals NHS Foundation Trust, London, United Kingdom
²National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, United Kingdom
³University College London and the Royal Free London NHS Foundation Trust, London, United Kingdom

Dikelele Elessa, MD^1,2*, Stephanie Harel, MD^1,2*, Alexis Talbot, MD^1,2*, Marion Malphettes, MD^2,3*, Catherine Thieblemont, MD, PhD^2,4, Frederic Davi, MD, PhD^5*, Odile Maarek, MD^6*, Bertrand Arnulf, MD, PhD^1,2* and Bruno Royer, MD^2,7*

¹Department of Immuno hematology, Hôpital Saint-Louis, Assistance Publique – Hôpitaux de Paris, Paris, France
²University of Paris, Paris, France
³Department of Clinical Immunology, Hôpital Saint-Louis, Assistance Publique – Hôpitaux de Paris, PARIS, FRA
⁴Department of Hemato-Oncology, Hôpital Saint-Louis, Assistance Publique – Hôpitaux de Paris, Paris, France
⁵Laboratory of Hematology, Hopital Pitié-Salpêtrière, Assistance Publique – Hôpitaux de Paris, Paris, FRA
⁶Laboratory of Hematology, Hôpital Saint-Louis, Assistance Publique – Hôpitaux de Paris, Paris, France
⁷Department of Immuno hematology, Hôpital Saint-Louis, Assistance Publique – Hôpitaux de Paris, Paris, France

Thomas A Ollila, MD^1,2, James Butera, MD^1,2, Pamela C Egan, MD^1,2, John L Reagan, MD^1,2, Anthony G Thomas, DO^2,3, Inna Yakirevich, NP^4*, Kelsey MacKinnon^5*, Jeannine Margolis^5*, Valerie Rosati^6*, Jessica McMahon, RN^7*, Jordan Robison, CRA^7* and Adam J Olszewski, MD^1,2

¹Division of Hematology-Oncology, Rhode Island Hospital, Providence, RI
²Brown University, Providence, RI
³The Miriam Hospital, Providence, RI
⁴Lifespan Cancer Institute, Providence, RI
⁵Brown University Oncology Research Group (BrUOG), Providence, RI
⁶Lifespan Oncology Clinical Research, The Miriam Hospital, Providence, RI
⁷Lifespan Oncology Clinical Research, Rhode Island Hospital, Providence, RI

David Proudman, MSc, MPH^1*, Dave Nellesen, Ph.D.^2*, Deepshekhar Gupta, MS^2*, Deyaa Adib, MD^3*, Jay Yang, PhD^3*, Michael Keith, PhD, PharmD^3* and Khalid Mamlouk, PharmD, BCOP³

¹Analysis Group, Inc., Oakland, CA
²Analysis Group, Inc., Menlo Park, CA
³Epizyme, Inc., Cambridge, MA